Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study.
Benhamou, Ygal
Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study. [electronic resource] - American journal of hematology 12 2016 - 1246-1251 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1096-8652
10.1002/ajh.24559 doi
ADAMTS13 Protein--blood
Adult
B-Lymphocytes--drug effects
Disease-Free Survival
Drug Administration Schedule
Female
Historically Controlled Study
Humans
Lymphocyte Depletion
Male
Middle Aged
Plasma Exchange
Platelet Count
Purpura, Thrombotic Thrombocytopenic--drug therapy
Rituximab--administration & dosage
Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study. [electronic resource] - American journal of hematology 12 2016 - 1246-1251 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1096-8652
10.1002/ajh.24559 doi
ADAMTS13 Protein--blood
Adult
B-Lymphocytes--drug effects
Disease-Free Survival
Drug Administration Schedule
Female
Historically Controlled Study
Humans
Lymphocyte Depletion
Male
Middle Aged
Plasma Exchange
Platelet Count
Purpura, Thrombotic Thrombocytopenic--drug therapy
Rituximab--administration & dosage